Literature DB >> 28416267

Molecular Mechanisms and Targets of Therapy for Hepatocellular Carcinoma.

Vivian Klungboonkrong1, Dola Das2, Gordon McLennan3.   

Abstract

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. HCC develops through a multistep process that involves the local tumor microenvironment, intracellular signaling pathways, and altered metabolic system that allows the cancer proliferation. Understanding the mechanisms of tumor development and progression is critical to developing improved therapies aimed at better survival. This article reviews the molecular mechanisms of HCC development and highlights the potential therapeutic targets for treatments.
Copyright © 2017 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28416267     DOI: 10.1016/j.jvir.2017.03.002

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  14 in total

Review 1.  The functional role of exosome in hepatocellular carcinoma.

Authors:  Hongyu Liu; Baoguo Li
Journal:  J Cancer Res Clin Oncol       Date:  2018-07-30       Impact factor: 4.553

2.  Limitations of Fluorine 18 Fluoromisonidazole in Assessing Treatment-induced Tissue Hypoxia after Transcatheter Arterial Embolization of Hepatocellular Carcinoma: A Prospective Pilot Study.

Authors:  Rajesh P Shah; Paul F Laeseke; Lewis K Shin; Frederick T Chin; Nishita Kothary; George M Segall
Journal:  Radiol Imaging Cancer       Date:  2022-05

3.  CBX3 regulated by miR-139 promotes the development of HCC by regulating cell cycle progression.

Authors:  Pan Zhang; Xiaoyan Yang; Zhongming Zha; Yumeng Zhu; Guoqiang Zhang; Guotao Li
Journal:  Cell Cycle       Date:  2022-04-26       Impact factor: 5.173

4.  Processing of N5-substituted formamidopyrimidine DNA adducts by DNA glycosylases NEIL1 and NEIL3.

Authors:  Irina G Minko; Plamen P Christov; Liang Li; Michael P Stone; Amanda K McCullough; R Stephen Lloyd
Journal:  DNA Repair (Amst)       Date:  2018-11-05

5.  CXCR3 confers sorafenib resistance of HCC cells through regulating metabolic alteration and AMPK pathway.

Authors:  Ying Ren; Yue Kai Gu; Zhen Li; Guang Zi Xu; Yang Meng Zhang; Min Xin Dong; Ying Wang; Xi Bing Zhou
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

6.  [Identification of differentially expressed genes in peripheral blood mononuclear cells of patients with hepatocellular carcinoma and its regulatory network analysis].

Authors:  Yongzhi Lun; Jie Sun
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2019-04-25

7.  ZEB1 serves an oncogenic role in the tumourigenesis of HCC by promoting cell proliferation, migration, and inhibiting apoptosis via Wnt/β-catenin signaling pathway.

Authors:  Liang-Yun Li; Jun-Fa Yang; Fan Rong; Zhi-Pan Luo; Shuang Hu; Hui Fang; Ying Wu; Rui Yao; Wei-Hao Kong; Xiao-Wen Feng; Bang-Jie Chen; Jun Li; Tao Xu
Journal:  Acta Pharmacol Sin       Date:  2021-01-29       Impact factor: 7.169

8.  Inhibition of CUG-binding protein 1 and activation of caspases are critically involved in piperazine derivative BK10007S induced apoptosis in hepatocellular carcinoma cells.

Authors:  Ju-Ha Kim; Hee Young Kwon; Dong Hoon Ryu; Min-Ho Nam; Bum Sang Shim; Jin Han Kim; Jae Yeol Lee; Sung-Hoon Kim
Journal:  PLoS One       Date:  2017-10-16       Impact factor: 3.240

9.  A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma.

Authors:  Chunmei Guo; Chao Gao; Dongting Zhao; Jiahui Li; Jinxia Wang; Xujuan Sun; Qinlong Liu; Lihong Hao; Frederick T Greenaway; Yuxiang Tian; Shuqing Liu; Ming-Zhong Sun
Journal:  J Exp Clin Cancer Res       Date:  2020-04-23

10.  Cordycepin suppresses the migration and invasion of human liver cancer cells by downregulating the expression of CXCR4.

Authors:  Zhongrong Guo; Wen Chen; Guisen Dai; Yuanliang Huang
Journal:  Int J Mol Med       Date:  2019-10-31       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.